SangeetaRHingoraniMDMPH
Pediatric Nephrology • Seattle, WAProfessor, Pediatrics, University of Washington School of Medicine
Dr. Hingorani is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
4800 Sand Point Way Ne
Seattle, WA 98105Phone+1 206-987-2524Fax+1 206-987-2636
Education & Training
University of WashingtonFellowship, Pediatric Nephrology, 1998 - 2002
University of Washington School of Public HealthMPH, Epidemiology, 1998 - 2000- University of WashingtonResidency, Pediatrics, 1993 - 1996
Albert Einstein College of MedicineClass of 1993
Certifications & Licensure
WA State Medical License 1996 - 2026- American Board of Pediatrics Pediatrics
- American Board of Pediatrics Pediatric Nephrology
Awards, Honors, & Recognition
- Regional Top Doctor Castle Connolly, 2014
Clinical Trials
- Nephrotic Syndrome Study Network Start of enrollment: 2010 Apr 01
- A Phase 2/3 Trial of the Efficacy and Safety of Bardoxolone Methyl in Patients With Alport Syndrome - CARDINAL Start of enrollment: 2017 Mar 02
Publications & Presentations
PubMed
- Growth in children with nephrotic syndrome: a post hoc analysis of the NEPTUNE study.Aesha Maniar, Debbie S Gipson, Tammy Brady, Tarak Srivastava, David T Selewski
Pediatric Nephrology. 2024-09-01 - 1 citationsAn expert discussion on the atypical hemolytic uremic syndrome nomenclature-identifying a road map to precision: a report of a National Kidney Foundation Working Group.Carla M Nester, David L Feldman, Richard Burwick, Spero Cataland, Shruti Chaturvedi
Kidney International. 2024-09-01 - 1 citationsLongitudinal analysis of blood pressure and lipids in childhood nephrotic syndrome.Johnathon Carboni, Elizabeth Thomas, Debbie S Gipson, Tammy M Brady, Tarak Srivastava
Pediatric Nephrology. 2024-07-01
Abstracts/Posters
- Soluble C5b-9 As a Prognostic Biomarker for Thrombotic Microangiopathy at the Onset of Graft-Versus-Host DiseaseSangeeta R Hingorani, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
- D-Dimer As a Prognostic Biomarker for Venous Thromboembolism after Hematopoietic Cell TransplantationSangeeta R Hingorani, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
- Comparative Effectiveness of Rasburicase Versus Allopurinol for Cancer Patients with Renal Dysfunction and HyperuricemiaSangeeta R Hingorani, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
Press Mentions
Author Correction: Diagnosis, Grading and Management of Toxicities from Immunotherapies in Children, Adolescents and Young Adults with CancerMarch 17th, 2021
Grant Support
- Chronic Kidney Disease In Survivors Of Hematopoietic Cell TransplantNational Institute Of Diabetes And Digestive And Kidney Diseases2008–2011
- Renal Injury After Hematopoietic Stem Cell TransplantNational Center For Research Resources2004–2007
- Renal Injury After Hematopoietic Stem Cell TransplantNational Institute Of Diabetes And Digestive And Kidney Diseases2003–2007
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
